Laboratoires du Centre: Correction made to the company’s consolidation financial report for the first quarter of 2022 completed at Mops







close

Provided by: Center Laboratories, Inc.

SEQ_NO

1

announcement date

2022/06/08

Announcement time

18:53:44

Matter

 Correction made on the Company's Consolidation
Financial Report for the Q1 2022 filled to the Mops

Date of events

2022/06/08

What item it responds to

paragraph 53

Statement

1.Date of occurrence of the event:2022/06/08
2.Company name:Center Laboratories, Inc.
3.Relationship to the Company (please enter "head
  office" or  "subsidiaries"):Head office
4.Reciprocal shareholding ratios:NA
5.Cause of occurrence:
Newly added notes to the Administrative Expenses from Consolidated of
Comprehensive Income Statement of the Company's Q1 2022 Consolidated
Financial Report
6.Information items/ statements to be corrected:
On P7 Consolidated of Comprehensive Income Statement and P35 item 六.15
Provision on Debts
7.Amounts/ contents/ number of page to be corrected:
P7 Administrative Expenses Unannotated
8.Amounts/ contents/ number of page after correction:
(1) Added notes 六.15 to P7 Administrative Expenses
(2) Newly added illustration on P35 item 六.15 Provision on Debts
9.Countermeasures:
In Q1 2022, the market price of listed OTC stocks which held by Bioengine
Capital Inc. fell. According to the management agreement, recalculating
the performance bonus that was book as a debt reserve; simultaneously,
reduced the amount of debt reserve and write down 175,7000 thousand of
Administrative Expense (for Performance Bonus). Consequently, lead to
a negative Administrative Expense under Operating Expense on Q1 2022
Consolidated Income Statement
10.Any other matters that need to be specified:None.

Disclaimer

Center Laboratories Inc. published this content on June 08, 2022 and is solely responsible for the information contained therein. Distributed by Audienceunedited and unmodified, on Jun 08, 2022 11:01:03 AM UTC.

Public now 2022

All news about CENTER LABORATORIES, INC.

Sales 2021 500M
16.9 million
16.9 million
Net income 2021 1,816 million
61.5 million
61.5 million
Net debt 2021 513M
17.4 million
17.4 million
PER 2021 ratio 17.3x
2021 performance 4.13%
Capitalization 30,353 million
1,029 million
1,029 million
EV / Sales 2020 48.2x
EV / Sales 2021 62.1x
# of employees
Floating 75.5%

Chart CENTER LABORATORIES, INC.


Duration :

Period :




Center Laboratories, Inc. Technical Analysis Chart |  MarketScreener

Trends in Technical Analysis CENTER LABORATORIES, INC.

Short term Middle term Long term
Tendencies Bearish Neutral Neutral



Evolution of the income statement


Comments are closed.